通过印米他辛和潘托普拉来调节脂肪生成和脂质生成
Bita Entezari1, Hasan Akbaba2, Hande Gurer-Orhan1
1Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Ege University, 35040 Izmir, Türkiye.
概括
这项研究探讨了常见的怀孕药物印米他辛和潘托普拉是否促进脂肪细胞生长 (脂肪生成). 结果表明,这些药物可能具有肥胖效应,需要进一步调查.
科学领域:
- 内分泌学 在内分泌学.
- 代谢过程中的代谢.
- 药理学 药理学是指药理学的学科.
背景情况:
- 包括工业化学品和药品在内的内分泌干扰剂也与此有关.
- 肥胖的原因是肥胖.
- 可能会破坏脂肪组织中的代谢过程.
- 有限的研究已经评估了药物的肥胖性不良影响,特别是那些在怀孕期间使用的药物.
- 了解常规处方药对代谢健康的影响对于公共健康至关重要.
研究的目的:
- 为了研究印梅他辛和潘托普拉的体外脂肪和脂质潜力.
- 评估这些药品对脂质积累,阿迪波涅克丁水平,G3PDH活性和阿迪波基因/蛋白质表达的影响.
- 评估怀孕期间处方的药物的潜在肥胖效应.
主要方法:
- 利用3T3-L1细胞系,这是脂肪生成研究的标准模型.
- 在与它们的Cmax值相关的度下服用印梅他辛和潘托普拉.
- 量化了脂质积累,阿迪波涅克水平,G3PDH活性,并分析了阿迪波基因基因和蛋白质表达.
主要成果:
- 印梅他以剂量依赖的方式增加了脂质积累.
- 潘托普拉在最高测试度时增加了脂质积累.
- 这两种药物都提高了阿迪波涅克丁水平,并改变了关键的脂/脂质转录因子的表达.
结论:
- 印米他辛和潘托普拉通过不同的机制表现出潜在的体外肥胖效应.
- 这些发现表明,胎儿发育过程中代谢途径可能受到干扰.
- 需要进一步的体内和流行病学研究来证实这些药物的肥胖性潜力.
更多相关视频
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
2.8K
04:46Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
1.4K
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
GPCRs Regulate Adenylyl Cylase Activity
5.4K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.4K
Cholesterol: Significance and Regulation
533
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
533
Glucagon-like Receptor Agonists
313
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
313
